Carefirst of Maryland, Inc. et al v. Amgen, Inc. et al
Case Number:
2:24-cv-00484
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Glasser & Glasser
- Hagens Berman
- Kaufman & Canoles
- Lowey Dannenberg
- Munger Tolles
- Radice Law Firm
- Wexler Boley
- Zimmer Citron
Companies
Sectors & Industries:
-
January 09, 2025
Amgen Says Enbrel Protected By Legit Patents, Rulings
Amgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper competition for Enbrel, arguing the blockbuster arthritis treatment is protected by legitimate patents and court rulings of validity.
-
August 07, 2024
Amgen Waged Lawfare To Overcharge For Drug, Suit Claims
Maryland-based independent licensees of the Blue Cross Blue Shield Association claim pharmaceutical giant Amgen Inc. and its subsidiaries have engaged in unlawful monopolistic practices that have inflated the cost of the blockbuster drug Enbrel.